Social Media Ideas for Biotech Food Drug

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

<![CDATA[The Status of Nuvation Bio’s Pipeline]]>

Protecting Biotech Innovation In The Platform Knowledge Era

Following the U.S. Food and Drug Administration's recent shift toward leveraging prior and platform knowledge in biotechnology, companies should protect their innovations by guardi...

PARLIAMENT QUESTION: Contribution of BioE3 Policy

 PARLIAMENT QUESTION: Contribution of BioE3 PolicyPosted On: 06 AUG 2026 2:56PM by PIB DelhiThe Department of Biotechnology (DBT) has identified six thematic verticals in the BioE3...

APEC Holds High-Level Policy Dialogue on Agricultural Biotechnology

With $263M, LifeMine unearths a new drug for organ transplants

Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...

Biocontrol Technologies and Wilbur-Ellis Enter Distribution Agreement

Biocontrol Technologies has entered into a distribution agreement with Wilbur-Ellis Agribusiness for the distribution of T34 Biocontrol® in the U.S. market. T34 Biocontrol® is a bi...

Biopharma Hungry for GLP-1 Receptor Agonist Manufacturing Skills

NIBRT predicts that the market for GLP-1 receptor agonist-based diabetes and obesity meds will increase demand for biopharmaceutical engineers with a mix of synthetic chemistry and...

New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem

Addressing shifts in the global clinical development ecosystem and how academia and biotech can better partner to develop new therapies for patients.

The State of Biotech 2026

The world of biotech is showing strong signs of growth and clinical impact while also experiencing new challenges. The explosion of AI is reshaping areas from drug discovery and pr...

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Biotech deals surge to record as fear of missing out grips Big Pharma

Prospect of patents expiring on lucrative drugs prompts drugmakers to hunt for next blockbuster medicines

Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute

Teva believes the therapy has “pipeline-in-a-product” potential. Elsewhere, a high-stakes trial was paused and GSK advanced a competitor to Moderna’s flu shot.

<![CDATA[U.S. Rare Disease Biotech Investing Rises After FDA’s PRV Program Renewal: Report ]]>

From his parents’ basement to your medicine cabinet: Absci CEO endeavors to create biotech’s Apple

The overwhelming demand for GLP-1 weight loss drugs has reshaped the drug market, empowering consumers to take charge of their own health and removing barriers between their wallet...

Celonic and Leukocare Collaborate to Support Complex Biologics and Advanced Drug Development

The collaboration brings together Celonic’s expertise in cell line development, drug substance process development, intensified bioprocessing, and GMP manufacturing with Leukocare’...

Algae-Based Food Product Development Earns Gates Foundation Award

Mingyu Qiao, PhD’s recent work focused on DHA, critical to fetal and infant brain and eye development. The DHA will be produced in a microalgal strain isolated in Qiao’s lab. The p...

BioXcel

BioXcel Anonymous (not verified) Sun, 08/30/2026 - 09:43 field_thread_url https://cafepharma.com/boards/threads/bioxcel.674502/ board na...

Bayer to bring 10 products to world market in 10 years

In soy, ‘Vyconic 1’ is expected to be introduced next year in the US and Canada, and ‘Intacta 5+’ is expected to be introduced in the 2027-28 growing season in Brazil

<![CDATA[The Path from Discovery to Global Commercialization]]>

Biocon sees stronger H2 on US biosimilar launches, regulatory easing

The US regulator’s decision to move away from subjecting companies to undertake mandatory efficacy trials in phase-3 bodes well for incumbents such as Biocon

eGreen Biotek Expands Its Global Medicinal Mushroom Supply Strategy Through U.S. Collaboration

Taiwan mushroom biotechnology company eGreen Biotek is advancing a U.S. collaboration with AMP Laboratory to connect ingredient development, cultivation and manufacturing capabilit...

Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances

The new lawsuits add to a web of legal disputes over technology involved in COVID vaccines. Elsewhere, a prolific AI biotech inked another deal and Insmed strengthened support for...

A plant-source Vitamin D3 looks to light-up Fermenta Biotech’s prospects

Fermenta has a presence in the regular Vitamin D3 segment, but the company explored a sustainable natural source and found it in the byproduct of soyabean oil. Oil from soyabean se...